Registro:

Referencias:

• Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation (2011) Cell., 144, pp. 646-674
• Trinchieri, G., Cancer and inflammation: an old intuition with rapidly evolving new concepts (2012) Annu. Rev. Immunol., 30, pp. 677-706
• Balkwill, F.R., Mantovani, A., Cancer-related inflammation: common themes and therapeutic opportunities (2012) Semin. Cancer Biol., 22, pp. 33-40
• Mantovani, A., Molecular pathways linking inflammation and cancer (2010) Curr. Mol. Med., 10, pp. 369-373
• Gubin, M.M., Schreiber, R.D., CANCER. the odds of immunotherapy success (2015) Science., 350, pp. 158-159
• Rabinovich, G.A., Gabrilovich, D., Sotomayor, E.M., Immunosuppressive strategies that are mediated by tumor cells (2007) Annu. Rev. Immunol., 25, pp. 267-296
• Mariño, K., Bones, J., Kattla, J.J., Rudd, P.M., A systematic approach to protein glycosylation analysis: a path through the maze (2010) Nat. Chem. Biol., 6, pp. 713-723
• Elola, M.T., Blidner, A.G., Ferragut, F., Bracalente, C., Rabinovich, G.A., Assembly, organization and regulation of cell-surface receptors by lectin–glycan complexes (2015) Biochem. J., 469, pp. 1-16
• van Kooyk, Y., Rabinovich, G.A., Protein–glycan interactions in the control of innate and adaptive immune responses (2008) Nat. Immunol., 9, pp. 593-601
• Blidner, A.G., Mendez-Huergo, S.P., Cagnoni, A.J., Rabinovich, G.A., Re-wiring regulatory cell networks in immunity by galectin–glycan interactions (2015) FEBS Lett., 589, pp. 3407-3418
• Pinho, S.S., Reis, C.A., Glycosylation in cancer: mechanisms and clinical implications (2015) Nat. Rev. Cancer., 15, pp. 540-555
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin–glycan interactions in autoimmunity and cancer (2012) Immunity., 36, pp. 322-335
• Croci, D.O., Cerliani, J.P., Pinto, N.A., Morosi, L.G., Rabinovich, G.A., Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment (2014) Glycobiology., 24, pp. 1283-1290
• Hakomori, S., Glycosylation defining cancer malignancy: new wine in an old bottle (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 10231-10233
• Bassaganas, S., Allende, H., Cobler, L., Ortiz, M.R., Llop, E., de Bolos, C., Peracaula, R., Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines (2015) Cytokine., 75, pp. 197-206
• Higai, K., Miyazaki, N., Azuma, Y., Matsumoto, K., Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene (2006) FEBS Lett., 580, pp. 6069-6075
• Azuma, Y., Murata, M., Matsumoto, K., Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro (2000) Clin. Chim. Acta., 294, pp. 93-103
• Nolz, J.C., Harty, J.T., IL-15 regulates memory CD8 + T cell O-glycan synthesis and affects trafficking (2014) J. Clin. Invest., 124, pp. 1013-1026
• Carlow, D.A., Corbel, S.Y., Williams, M.J., Ziltener, H.J., IL-2, -4, and -15 differentially regulate O-glycan branching and P-selectin ligand formation in activated CD8 T cells (2001) J. Immunol., 167, pp. 6841-6848
• Lau, K.S., Dennis, J.W., N-glycans in cancer progression (2008) Glycobiology., 18, pp. 750-760
• Miwa, H.E., Song, Y., Alvarez, R., Cummings, R.D., Stanley, P., The bisecting GlcNAc in cell growth control and tumor progression (2012) Glycoconj. J., 29, pp. 609-618
• Kimura, T., Finn, O.J., MUC1 immunotherapy is here to stay (2013) Expert. Opin. Biol. Ther., 13, pp. 35-49
• Bull, C., den Brok, M.H., Adema, G.J., Sweet escape: sialic acids in tumor immune evasion (2014) Biochim. Biophys. Acta., 1846, pp. 238-246
• Dam, T.K., Brewer, C.F., Multivalent lectin–carbohydrate interactions energetics and mechanisms of binding (2010) Adv. Carbohydr. Chem. Biochem., 63, pp. 139-164
• Cummings, R.D., Esko, J.D., Principles of Glycan Recognition (2009) Essentials of Glycobiology, , A. Varki R.D. Cummings J.D. Esko H.H. Freeze P. Stanley C.R. Bertozzi G.W. Hart M.E.,. Etzler 2nd edit. Cold Spring Harbor NY (Chapter 27; ISBN-13: 9780879697709)
• Brewer, C.F., Miceli, M.C., Baum, L.G., Clusters, bundles, arrays and lattices: novel mechanisms for lectin–saccharide-mediated cellular interactions (2002) Curr. Opin. Struct. Biol., 12, pp. 616-623
• Thiemann, S., Baum, L.G., Galectins and immune responses—just how do they do those things they do? (2016) Annu. Rev. Immunol., , (Feb 22. Epub ahead of print)
• Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat. Rev. Cancer, 5, pp. 29-41
• Lahm, H., Andre, S., Hoeflich, A., Fischer, J.R., Sordat, B., Kaltner, H., Wolf, E., Gabius, H.J., Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures (2001) J. Cancer Res. Clin. Oncol., 127, pp. 375-386
• Langbein, S., Brade, J., Badawi, J.K., Hatzinger, M., Kaltner, H., Lensch, M., Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance (2007) Histopathology., 51, pp. 681-690
• Remmelink, M., de Leval, L., Decaestecker, C., Duray, A., Crompot, E., Sirtaine, N., Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential (2011) Histopathology., 58, pp. 543-556
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res., 73, pp. 86-96
• Schulkens, I.A., Heusschen, R., van den Boogaart, V., van Suylen, R.J., Dingemans, A.M., Griffioen, A.W., Thijssen, V.L., Galectin expression profiling identifies galectin-1 and Galectin-9Delta5 as prognostic factors in stage I/II non-small cell lung cancer (2014) PLoS One., 9 (9). , e107988
• El Leithy, A.A., Helwa, R., Assem, M.M., Hassan, N.H., Expression profiling of cancer-related galectins in acute myeloid leukemia (2015) Tumour Biol., 36, pp. 7929-7939
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res., 70, pp. 6216-6224
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J. Exp. Med., 209, pp. 1985-2000
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Mendez-Huergo, S.P., Mascanfroni, I.D., Dergan-Dylon, S., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell., 156, pp. 744-758
• Bacigalupo, M.L., Manzi, M., Espelt, M.V., Gentilini, L.D., Compagno, D., Laderach, D.J., Galectin-1 triggers epithelial–mesenchymal transition in human hepatocellular carcinoma cells (2015) J. Cell. Physiol., 230, pp. 1298-1309
• Liu, F.T., Patterson, R.J., Wang, J.L., Intracellular functions of galectins (2002) Biochim. Biophys. Acta., 1572, pp. 263-273
• Elad-Sfadia, G., Haklai, R., Balan, E., Kloog, Y., Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity (2004) J. Biol. Chem., 279, pp. 34922-34930
• Su, Y.C., Davuluri, G.V., Chen, C.H., Shiau, D.C., Chen, C.C., Chen, C.L., Lin, Y.S., Chang, C.P., Galectin-1-induced autophagy facilitates cisplatin resistance of hepatocellular carcinoma (2016) PLoS One., 11. , e0148408
• Hirabayashi, J., Kasai, K.I., Evolution of animal lectins (1998) Prog. Mol. Subcell. Biol., 19, pp. 45-88
• Nickel, W., The mystery of nonclassical protein secretion. a current view on cargo proteins and potential export routes (2003) Eur. J. Biochem., 270, pp. 2109-2119
• Hirabayashi, J., Hashidate, T., Arata, Y., Nishi, N., Nakamura, T., Hirashima, M., Oligosaccharide specificity of galectins: a search by frontal affinity chromatography (2002) Biochim. Biophys. Acta., 1572, pp. 232-254
• Blixt, O., Head, S., Mondala, T., Scanlan, C., Huflejt, M.E., Alvarez, R., Bryan, M.C., Printed covalent glycan array for ligand profiling of diverse glycan binding proteins (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 17033-17038
• Nagae, M., Nishi, N., Nakamura-Tsuruta, S., Hirabayashi, J., Wakatsuki, S., Kato, R., Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue (2008) J. Mol. Biol., 375, pp. 119-135
• Rabinovich, G.A., Toscano, M.A., Turning “sweet” on immunity: galectin–glycan interactions in immune tolerance and inflammation (2009) Nat. Rev. Immunol., 9, pp. 338-352
• Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol., 8, pp. 825-834
• Amano, M., Galvan, M., He, J., Baum, L.G., The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death (2003) J. Biol. Chem., 278, pp. 7469-7475
• Stowell, S.R., Arthur, C.M., Mehta, P., Slanina, K.A., Blixt, O., Leffler, H., Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens (2008) J. Biol. Chem., 283, pp. 10109-10123
• Ideo, H., Matsuzaka, T., Nonaka, T., Seko, A., Yamashita, K., Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans (2011) J. Biol. Chem., 286, pp. 11346-11355
• Swaminathan, G.J., Leonidas, D.D., Savage, M.P., Ackerman, S.J., Acharya, K.R., Selective recognition of mannose by the human eosinophil Charcot–Leyden crystal protein (galectin-10): a crystallographic study at 1.8 A resolution (1999) Biochemistry., 38, p. 15406
• Stillman, B.N., Hsu, D.K., Pang, M., Brewer, C.F., Johnson, P., Liu, F.T., Baum, L.G., Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death (2006) J. Immunol., 176, pp. 778-789
• Wang, J., Lu, Z.H., Gabius, H.J., Rohowsky-Kochan, C., Ledeen, R.W., Wu, G., Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis (2009) J. Immunol., 182, pp. 4036-4045
• Kouo, T., Huang, L., Pucsek, A.B., Cao, M., Solt, S., Armstrong, T., Jaffee, E., Galectin-3 shapes antitumor immune responses by suppressing CD8 + T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells (2015) Cancer Immunol. Res., 3, pp. 412-423
• Carcamo, C., Pardo, E., Oyanadel, C., Bravo-Zehnder, M., Bull, P., Caceres, M., Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells (2006) Exp. Cell Res., 312, pp. 374-386
• Eshkar Sebban, L., Ronen, D., Levartovsky, D., Elkayam, O., Caspi, D., Aamar, S., The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation (2007) J. Immunol., 179, pp. 1225-1235
• Zhu, C., Anderson, A.C., Schubart, A., Xiong, H., Imitola, J., Khoury, S.J., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity (2005) Nat. Immunol., 6, pp. 1245-1252
• Wu, C., Thalhamer, T., Franca, R.F., Xiao, S., Wang, C., Hotta, C., Galectin-9–CD44 interaction enhances stability and function of adaptive regulatory T cells (2014) Immunity., 41, pp. 270-282
• Thiemann, S., Man, J.H., Chang, M.H., Lee, B., Baum, L.G., Galectin-1 regulates tissue exit of specific dendritic cell populations (2015) J. Biol. Chem., 290, pp. 22662-22677
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol., 10, pp. 981-991
• Fulcher, J.A., Chang, M.H., Wang, S., Almazan, T., Hashimi, S.T., Eriksson, A.U., Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling (2009) J. Biol. Chem., 284, pp. 26860-26870
• Starossom, S.C., Mascanfroni, I.D., Imitola, J., Cao, L., Raddassi, K., Hernandez, S.F., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration (2012) Immunity., 37, pp. 249-263
• Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene., 27, pp. 3746-3753
• Jouve, N., Despoix, N., Espeli, M., Gauthier, L., Cypowyj, S., Fallague, K., The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells (2013) J. Biol. Chem., 288, pp. 2571-2579
• Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response (2010) J. Exp. Med., 207, pp. 1981-1993
• Delgado, V.M., Nugnes, L.G., Colombo, L.L., Troncoso, M.F., Fernandez, M.M., Malchiodi, E.L., Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8 (2011) FASEB J., 25, pp. 242-254
• Rabinovich, G., Castagna, L., Landa, C., Riera, C.M., Sotomayor, C., Regulated expression of a 16-kd galectin-like protein in activated rat macrophages (1996) J. Leukoc. Biol., 59, pp. 363-370
• Tesone, A.J., Rutkowski, M.R., Brencicova, E., Svoronos, N., Perales-Puchalt, A., Stephen, T.L., Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells (2016) Cell Rep., 14, pp. 1774-1786
• Fuertes, M.B., Molinero, L.L., Toscano, M.A., Ilarregui, J.M., Rubinstein, N., Fainboim, L., Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase (2004) Mol. Cell. Biochem., 267, pp. 177-185
• Zuñiga, E., Rabinovich, G.A., Iglesias, M.M., Gruppi, A., Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis (2001) J. Leukoc. Biol., 70, pp. 73-79
• Garin, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollon, E., Wait, R., Lechler, R.I., Galectin-1: a key effector of regulation mediated by CD4 + CD25 + T cells (2007) Blood., 109, pp. 2058-2065
• Kopcow, H.D., Rosetti, F., Leung, Y., Allan, D.S., Kutok, J.L., Strominger, J.L., T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1 (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 18472-18477
• Dyer, K.D., Rosenberg, H.F., Transcriptional regulation of galectin-10 (eosinophil Charcot–Leyden crystal protein): a GC box (-44 to -50) controls butyric acid induction of gene expression (2001) Life Sci., 69, pp. 201-212
• Kubach, J., Lutter, P., Bopp, T., Stoll, S., Becker, C., Huter, E., Human CD4 + CD25 + regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function (2007) Blood., 110, pp. 1550-1558
• Thijssen, V.L., Heusschen, R., Caers, J., Griffioen, A.W., Galectin expression in cancer diagnosis and prognosis: a systematic review (2015) Biochim. Biophys. Acta., 1855, pp. 235-247
• Mendez-Huergo, S.P., Maller, S.M., Farez, M.F., Marino, K., Correale, J., Rabinovich, G.A., Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation (2014) Cytokine Growth Factor Rev., 25, pp. 247-255
• Rubinstein, N., Alvarez, M., Zwirner, N., Toscano, M., Ilarregui, J., Bravo, A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor-immune privilege (2004) Cancer Cell., 5, pp. 241-251
• Cedeno-Laurent, F., Opperman, M.J., Barthel, S.R., Hays, D., Schatton, T., Zhan, Q., He, X., Dimitroff, C.J., Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity (2012) J. Investig. Dermatol., 132, pp. 410-420
• Rostoker, R., Yaseen, H., Schif-Zuck, S., Lichtenstein, R.G., Rabinovich, G.A., Ariel, A., Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype (2013) Prostaglandins Other Lipid Mediat., 107, pp. 85-94
• Rabinovich, G.A., Ariel, A., Hershkoviz, R., Hirabayashi, J., Kasai, K.I., Lider, O., Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 (1999) Immunology., 97, pp. 100-106
• He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration (2006) Lab. Investig., 86, pp. 578-590
• Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 13134-13139
• Gandhi, M.K., Moll, G., Smith, C., Dua, U., Lambley, E., Ramuz, O., Galectin-1 mediated suppression of Epstein–Barr virus specific T-cell immunity in classic Hodgkin lymphoma (2007) Blood., 110, pp. 1326-1329
• Ouyang, J., Juszczynski, P., Rodig, S.J., Green, M.R., O'Donnell, E., Currie, T., Viral induction and targeted inhibition of galectin-1 in EBV + posttransplant lymphoproliferative disorders (2011) Blood., 117, pp. 4315-4322
• Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res., 71, pp. 4423-4431
• Kuo, P.L., Huang, M.S., Cheng, D.E., Hung, J.Y., Yang, C.J., Chou, S.H., Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor (2012) J. Biol. Chem., 287, pp. 9753-9764
• Soldati, R., Berger, E., Zenclussen, A.C., Jorch, G., Lode, H.N., Salatino, M., Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments (2012) Int. J. Cancer, 131, pp. 1131-1141
• Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Mendez-Huergo, S.P., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2013) Cancer Res., 73, pp. 1107-1117
• Ito, K., Scott, S.A., Cutler, S., Dong, L.F., Neuzil, J., Blanchard, H., Ralph, S.J., Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress (2011) Angiogenesis., 14, pp. 293-307
• Martinez-Bosch, N., Fernandez-Barrena, M.G., Moreno, M., Ortiz-Zapater, E., Munne-Collado, J., Iglesias, M., Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation (2014) Cancer Res., 74, pp. 3512-3524
• Tang, D., Gao, J., Wang, S., Yuan, Z., Ye, N., Chong, Y., Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer (2015) Tumour Biol., 36, pp. 5617-5626
• Verschuere, T., Toelen, J., Maes, W., Poirier, F., Boon, L., Tousseyn, T., Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity (2014) Int. J. Cancer., 134, pp. 873-884
• Baker, G.J., Chockley, P., Yadav, V.N., Doherty, R., Ritt, M., Sivaramakrishnan, S., Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity (2014) Cancer Res., 74, pp. 5079-5090
• Rutkowski, M.R., Stephen, T.L., Svoronos, N., Allegrezza, M.J., Tesone, A.J., Perales-Puchalt, A., Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation (2015) Cancer Cell., 27, pp. 27-40
• Croci, D.O., Morande, P.E., Dergan-Dylon, S., Borge, M., Toscano, M.A., Stupirski, J.C., Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1 (2013) Leukemia., 27, pp. 1413-1416
• Cedeno-Laurent, F., Watanabe, R., Teague, J.E., Kupper, T.S., Clark, R.A., Dimitroff, C.J., Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma (2012) Blood., 119, pp. 3534-3538
• Roberts, A.A., Amano, M., Felten, C., Galvan, M., Sulur, G., Pinter-Brown, L., Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation (2003) Mod. Pathol., 16, pp. 543-551
• Rappl, G., Abken, H., Muche, J.M., Sterry, W., Tilgen, W., Andre, S., CD4 + CD7- leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death (2002) Leukemia., 16, pp. 840-845
• Lykken, J.M., Horikawa, M., Minard-Colin, V., Kamata, M., Miyagaki, T., Poe, J.C., Tedder, T.F., Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms (2016) Blood., , (pii: blood-2015-11-681130. Epub ahead of print)
• Demotte, N., Stroobant, V., Courtoy, P.J., Van Der Smissen, P., Colau, D., Luescher, I.F., Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes (2008) Immunity., 28, pp. 414-424
• Demotte, N., Wieers, G., Van Der Smissen, P., Moser, M., Schmidt, C., Thielemans, K., A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice (2010) Cancer Res., 70, pp. 7476-7488
• Peng, W., Wang, H.Y., Miyahara, Y., Peng, G., Wang, R.F., Tumor-associated galectin-3 modulates the function of tumor-reactive T cells (2008) Cancer Res., 68, pp. 7228-7236
• Fukumori, T., Takenaka, Y., Yoshii, T., Kim, H.R., Hogan, V., Inohara, H., CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis (2003) Cancer Res., 63, pp. 8302-8311
• Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans (2011) EMBO J., 30, pp. 3173-3185
• Wang, W., Guo, H., Geng, J., Zheng, X., Wei, H., Sun, R., Tian, Z., Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack (2014) J. Biol. Chem., 289, pp. 33311-33319
• Sakuishi, K., Jayaraman, P., Behar, S.M., Anderson, A.C., Kuchroo, V.K., Emerging Tim-3 functions in antimicrobial and tumor immunity (2011) Trends Immunol., 32, pp. 345-349
• Li, H., Wu, K., Tao, K., Chen, L., Zheng, Q., Lu, X., Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma (2012) Hepatology., 56, pp. 1342-1351
• Kang, C.W., Dutta, A., Chang, L.Y., Mahalingam, J., Lin, Y.C., Chiang, J.M., Apoptosis of tumor infiltrating effector TIM-3 + CD8 + T cells in colon cancer (2015) Sci. Rep., 5, p. 15659
• Dardalhon, V., Anderson, A.C., Karman, J., Apetoh, L., Chandwaskar, R., Lee, D.H., Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b + Ly-6G + myeloid cells (2010) J. Immunol., 185, pp. 1383-1392
• Nagahara, K., Arikawa, T., Oomizu, S., Kontani, K., Nobumoto, A., Tateno, H., Galectin-9 increases Tim-3 + dendritic cells and CD8 + T cells and enhances antitumor immunity via galectin-9–Tim-3 interactions (2008) J. Immunol., 181, pp. 7660-7669
• Oomizu, S., Arikawa, T., Niki, T., Kadowaki, T., Ueno, M., Nishi, N., Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner (2012) Clin. Immunol., 143, pp. 51-58
• Leitner, J., Rieger, A., Pickl, W.F., Zlabinger, G., Grabmeier-Pfistershammer, K., Steinberger, P., TIM-3 does not act as a receptor for galectin-9 (2013) PLoS Pathog., 9. , e1003253
• Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 (2012) Nat. Immunol., 13, pp. 832-842
• Madireddi, S., Eun, S.Y., Lee, S.W., Nemčovičová, I., Mehta, A.K., Zajonc, D.M., Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies (2014) J. Exp. Med., 211, pp. 1433-1448
• Bunt, S.K., Yang, L., Sinha, P., Clements, V.K., Leips, J., Ostrand-Rosenberg, S., Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression (2007) Cancer Res., 67, pp. 10019-10026
• Sinha, P., Clements, V.K., Fulton, A.M., Ostrand-Rosenberg, S., Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells (2007) Cancer Res., 67, pp. 4507-4513
• Eruslanov, E., Daurkin, I., Ortiz, J., Vieweg, J., Kusmartsev, S., Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells (2010) J. Leukoc. Biol., 88, pp. 839-848
• Takizawa, H., Boettcher, S., Manz, M.G., Demand-adapted regulation of early hematopoiesis in infection and inflammation (2012) Blood., 119, pp. 2991-3002
• Ostrand-Rosenberg, S., Sinha, P., Myeloid-derived suppressor cells: linking inflammation and cancer (2009) J. Immunol., 182, pp. 4499-4506
• Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours (2012) Nat. Rev. Immunol., 12, pp. 253-268
• Youn, J.I., Nagaraj, S., Collazo, M., Gabrilovich, D.I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice (2008) J. Immunol., 181, pp. 5791-5802
• Rutkowski, M.R., Conejo-Garcia, J.R., TLR5 signaling, commensal microbiota and systemic tumor promoting inflammation: the three parcae of malignant progression (2015) Oncoimmunology., 4 (8). , e1021542
• Rutkowski, M.R., Conejo-Garcia, J.R., Size does not matter: commensal microorganisms forge tumor-promoting inflammation and antitumor immunity (2015) Oncoscience., 2, pp. 239-246
• Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity (2008) Blood., 111, pp. 4233-4244
• Novak, R., Dabelic, S., Dumic, J., Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages (2012) Biochim. Biophys. Acta., 1820, pp. 1383-1390
• Cubillos-Ruiz, J.R., Silberman, P.C., Rutkowski, M.R., Chopra, S., Perales-Puchalt, A., Song, M., ER stress sensor XBP1 controls antitumor immunity by disrupting dendritic cell homeostasis (2015) Cell., 161, pp. 1527-1538
• Scarlett, U., Rutkowski, M., Rauwerdink, A., Fields, J., Escovar-Fadul, X., Baird, J., Ovarian cancer progression is controlled by phenotypic changes in dendritic cells (2012) J. Exp. Med., 209, pp. 495-506
• Tuddenham, S., Sears, C.L., The intestinal microbiome and health (2015) Curr. Opin. Infect. Dis., 28, pp. 464-470
• Furusawa, Y., Obata, Y., Fukuda, S., Endo, T., Nakato, G., Takahashi, D., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells (2013) Nature., 504, pp. 446-450
• Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., Deroos, P., Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation (2013) Nature., 504, pp. 451-455
• Chappert, P., Bouladoux, N., Naik, S., Schwartz, R., Specific gut commensal flora locally alters T cell tuning to endogenous ligands (2013) Immunity., 38, pp. 1198-1210
• Duan, J., Chung, H., Troy, E., Kasper, D., Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells (2010) Cell Host Microbe., 7, pp. 140-150
• Ivanov, I.I., Frutos Rde, L., Manel, N., Yoshinaga, K., Rifkin, D.B., Sartor, R.B., Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine (2008) Cell Host Microbe., 4, pp. 337-349
• Wei, B., Wingender, G., Fujiwara, D., Chen, D.Y., McPherson, M., Brewer, S., Commensal microbiota and CD8 + T cells shape the formation of invariant NKT cells (2010) J. Immunol., 184, pp. 1218-1226
• Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment (2013) Science., 342, pp. 967-970
• Viaud, S., Saccheri, F., Mignot, G.G., Yamazaki, T., Daillére, R., Hannani, D., The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide (2013) Science., 342, pp. 971-976
• Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy (2015) Science, 110, pp. 1084-1089
• Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota (2015) Science., 350, pp. 1079-1084
• Rabinovich, G.A., Thijssen, V.L., Introduction to special issue: Galectins go with the flow (2014) Glycobiology., 24, p. 885
• Thijssen, V.L., Griffioen, A.W., Galectin-1 and − 9 in angiogenesis: a sweet couple (2014) Glycobiology., 24, pp. 915-920
• Funasaka, T., Raz, A., Nangia-Makker, P., Galectin-3 in angiogenesis and metastasis (2014) Glycobiology., 24, pp. 886-891
• Troncoso, M.F., Ferragut, F., Bacigalupo, M.L., Cardenas Delgado, V.M., Nugnes, L.G., Gentilini, L., Galectin-8: a matricellular lectin with key roles in angiogenesis (2014) Glycobiology., 24, pp. 907-914
• Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Galectin-1: a link between tumor hypoxia and tumor immune privilege (2005) J. Clin. Oncol., 23, pp. 8932-8941
• Zhao, X.Y., Zhao, K.W., Jiang, Y., Zhao, M., Chen, G.Q., Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells (2011) J. Biol. Chem., 286, pp. 36808-36819
• Mathieu, V., de Lassalle, E.M., Toelen, J., Mohr, T., Bellahcene, A., Van Goietsenoven, G., Galectin-1 in melanoma biology and related neoangiogenesis processes (2012) J. Investig. Dermatol., 132, pp. 2245-2254
• Carlini, M.J., Roitman, P., Nunez, M., Pallotta, M.G., Boggio, G., Smith, D., Clinical relevance of galectin-1 expression in non-small cell lung cancer patients (2014) Lung Cancer., 84, pp. 73-78
• Rabinovich, G.A., Cumashi, A., Bianco, G.A., Ciavardelli, D., Iurisci, I., D'Egidio, M., Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis (2006) Glycobiology., 16, pp. 210-220
• Tejler, J., Tullberg, E., Frejd, T., Leffler, H., Nilsson, U.J., Synthesis of multivalent lactose derivatives by 1,3-dipolar cycloadditions: selective galectin-1 inhibition (2006) Carbohydr. Res., 341, pp. 1353-1362
• Giguere, D., Bonin, M.A., Cloutier, P., Patnam, R., St-Pierre, C., Sato, S., Roy, R., Synthesis of stable and selective inhibitors of human galectins-1 and -3 (2008) Bioorg. Med. Chem., 16, pp. 7811-7723
• Iurisci, I., Cumashi, A., Sherman, A.A., Tsvetkov, Y.E., Tinari, N., Piccolo, E., Consorzio Interuniversitario Nazionale Per la, B.-O., Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis (2009) Anticancer Res., 29, pp. 403-410
• Stannard, K.A., Collins, P.M., Ito, K., Sullivan, E.M., Scott, S.A., Gabutero, E., Darren Grice, I., Ralph, S.J., Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model (2010) Cancer Lett., 299, pp. 95-110
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 15975-15980
• Dings, R.P., Miller, M.C., Nesmelova, I., Astorgues-Xerri, L., Kumar, N., Serova, M., Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding (2012) J. Med. Chem., 55, pp. 5121-5129
• Dings, R.P., Kumar, N., Miller, M.C., Loren, M., Rangwala, H., Hoye, T.R., Mayo, K.H., Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1 (2013) J. Pharmacol. Exp. Ther., 344, pp. 589-599
• Astorgues-Xerri, L., Riveiro, M.E., Tijeras-Raballand, A., Serova, M., Rabinovich, G.A., Bieche, I., OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis (2014) Eur. J. Cancer., 50, pp. 2463-2477
• Nangia-Makker, P., Hogan, V., Honjo, Y., Baccarini, S., Tait, L., Bresalier, R., Raz, A., Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin (2002) J. Natl. Cancer Inst., 94, pp. 1854-1862

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------